Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT07753239
NCT07753239Not yet recruitingNot Applicable

Efficacy of Oral Nutritional Supplementation Added to Usual Care in Community-dwelling Adults at Risk of Malnutrition and With Low Muscle Strength Following Acute Care

Abbott Nutrition7 sites in 1 country304 target enrollmentStarted: October 1, 2026Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
304
Locations
7
Primary Endpoint
Change in body weight
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The study aims to determine the effects of Oral Nutritional Supplement (ONS) added to usual care on body weight compared with usual care alone in community-dwelling adults aged 55 years and older who are at risk of malnutrition and have low muscle strength following acute care.

Participants randomized to receive either ONS twice daily for 180 days plus usual care, or usual care alone. Usual care includes individualized dietary counseling and standardized physical activity advice provided. The study will assess body weight, nutritional status, muscle strength, physical function, dietary intake, and safety outcomes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
55 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •At risk of malnutrition.
  • •At the point of hospital discharge, the admission was for an acute medical illness.
  • •Has low maximum handgrip strength.
  • •Estimated life expectancy of more than 12 months.
  • •Community ambulant.
  • •No other chronic disease.
  • •Able to communicate and follow instructions.
  • •Able to consume food and beverages orally.
  • •Willing to refrain from taking non-study oral nutritional supplements over the course of the study.
  • •Able and willing to follow study procedures.

Exclusion Criteria

  • •Index hospitalization admission was for a surgical procedure or a stroke/myocardial infarction.
  • •Diagnosed with type 1 or type 2 diabetes.
  • •Has an active infectious disease.
  • •Diagnosed with severe gastrointestinal disorders.
  • •With severe or unstable congestive heart failure.
  • •With chronic kidney disease stage 2 or higher, end-stage organ failure, or other pre-terminal condition.
  • •Has an active malignancy within the past five years or currently receiving treatment for malignancy.
  • •Has a severe or unstable musculoskeletal or neuromuscular disorder.
  • •Unable to perform a valid handgrip strength assessment.
  • •Any condition that makes the participant unsuitable for the study.
  • •Currently enrolled in another clinical study.
  • •Has an eating disorder, alcoholism or substance abuse.
  • •Has dementia, delirium, or a significant neurological or psychiatric disorder.
  • •Known allergy or intolerance to any ingredients of the study product.
  • •Continuous use of ONS for 14 days prior to the baseline visit.
  • •Has used herbal products, dietary supplements, or medications in the past 30 days that could affect body weight, appetite, or body composition.
  • •Presence of clinically significant ascites, pleural effusion, edema, or dehydration.

Arms & Interventions

Feeding: Intervention

Experimental

Intervention: ONS (Dietary Supplement)

Feeding: Intervention

Experimental

Intervention: Standard of Care (SOC) (Other)

Feeding: None

Other

Intervention: Standard of Care (SOC) (Other)

Outcomes

Primary Outcomes

Change in body weight

Time Frame: Day 0 to Day 180

Measured in kg

Secondary Outcomes

  • Change in body weight(Study Day 30, Study Day 90 and Study Day 180)
  • Body mass index (BMI)(Study Day 30, Study Day 90 and Study Day 180)
  • Calf circumference(Study Day 30, Study Day 90 and Study Day 180)
  • Mid-upper arm circumference (MUAC)(Study Day 30, Study Day 90 and Study Day 180)
  • Body composition(Study Day 30, Study Day 90 and Study Day 180)
  • Nutrition Risk(Study Day 30, Study Day 90 and Study Day 180)
  • Handgrip strength(Study Day 30, Study Day 90 and Study Day 180)
  • Short Physical Performance Battery (SPPB) total score(Study Day 30, Study Day 90 and Study Day 180)
  • Short Physical Performance Battery (SPPB) component scores(Study Day 30, Study Day 90 and Study Day 180)
  • 4-meter gait speed(Study Day 30, Study Day 90 and Study Day 180)
  • Chair stand time(Study Day 30, Study Day 90 and Study Day 180)
  • Energy, macronutrient and micronutrient intakes(Study Day 30, Study Day 90 and Study Day 180)
  • Energy, macronutrient and micronutrient adequacy(Study Day 30, Study Day 90 and Study Day 180)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (7)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Nutritional Supplementation to Improve Colorectal Cancer SurgeryColorectal Cancer
NCT07599501Istituto Clinico Humanitas190
Not yet recruiting
Not Applicable
A study to assess the effectiveness of an oral supplement in providing skin benefits.
CTRI/2024/11/076781Ichimaru Pharcos Co Ltd.40
Not yet recruiting
Not Applicable
Oral Nutritional Supplementation in Children With Growth Concerns
NCT07312201Société des Produits Nestlé (SPN)216
Not yet recruiting
Phase 3
oral collagen supplement and i-ipf in patient with temporomandibular joint disorder along with arthrocentesis procedure
CTRI/2024/06/068444Vaibhav Alone30
Not yet recruiting
Phase 2
Clinical study of nutritional product in the participant in managing high cholesterol.
CTRI/2024/07/069846Life Synergy150